Evidence map›Paper›PMID 41021803›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2025

Influence of the protein corona on hematopoietic stem and progenitor cell uptake and macrophage clearance of membrane-wrapped nanoparticles.

Eric H Sterin, Laura A Weinstein, Ashish Tiwari, George C Kramarenko, Chitran Roy Chowdhury, Kejian Li, Emily S Day

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Eric H SterinDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0000-0002-4705-5717
Laura A WeinsteinDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0009-0006-7586-3574
Ashish TiwariDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0000-0001-8520-1829
George C KramarenkoDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0000-0002-6990-5620
Chitran Roy ChowdhuryDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0009-0002-9185-9357
Kejian LiDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.
Emily S DayDepartment of Biomedical Engineering, University of Delaware, Newark, DE 19713.ORCID 0000-0002-8707-826X

Funding

Predictive Modeling & Optimal Control Framework for Model-Based Epidemic Response in DelawareP20GM103446 · NIGMS · UNIVERSITY OF DELAWARE · PI Shawn W Polson · 2012 to 2026
$67.2M
This renovation project will create over 1455 sq. ft. of state- of-the-art reseaP20GM104316 · NIGMS · UNIVERSITY OF DELAWARE · PI FOX, JOSEPH M · 2014 to 2024
$26.8M
Understanding synovial macrophage inflamm-aging within osteoarthritisP20GM139760 · NIGMS · UNIVERSITY OF DELAWARE · PI DAWN M ELLIOTT · 2021 to 2026
$19.1M
Pilot Research Subproject ProgramP30GM110758 · NIGMS · UNIVERSITY OF DELAWARE · PI POLENOVA, TATYANA · 2014 to 2018
$5.8M
Probing nano/bio interactions to understand and overcome biological barriers limiting nanomedicineR35GM149292 · NIGMS · UNIVERSITY OF DELAWARE · PI Emily S Day · 2023 to 2026
$1.6M
HHS | NIH | National Institute of General Medical Sciences (NIGMS) P20GM103446HHS | NIH | National Institute of General Medical Sciences (NIGMS) P20GM104316HHS | NIH | National Institute of General Medical Sciences (NIGMS) P20GM139760HHS | NIH | National Institute of General Medical Sciences (NIGMS) P30GM110758-02HHS | NIH | National Institute of General Medical Sciences (NIGMS) R35GM149292National Science Foundation (NSF) 2125703National Science Foundation (NSF) 2331440NIGMS NIH HHS P20 GM103446NIGMS NIH HHS P20 GM104316NIGMS NIH HHS P20 GM139760NIGMS NIH HHS P30 GM110758NIGMS NIH HHS R35 GM149292NSF | National Science Foundation Graduate Research Fellowship Program (GRFP) 1940700
6 · The paper itself

Abstract

The ideal delivery of therapeutic nanoparticles (NPs) to specific sites requires evading immune clearance and selectively binding target cells. Wrapping NPs in cell-derived membranes has shown promise in improving targeted delivery, but the mechanisms underlying this phenomenon are not fully understood. Protein corona (PC) formation on NPs can significantly alter their biological identity to influence biodistribution, making its characterization on membrane-wrapped NPs (MWNPs) and unwrapped NPs crucial. In this study, we compared MWNPs incorporating membranes derived from megakaryoblastic CHRF-288-11 cells, which can accumulate in bone marrow (BM) and preferentially bind hematopoietic stem and progenitor cells (HSPCs), with unwrapped NPs. We investigated differences in PC composition, macrophage uptake, target cell uptake, and biodistribution in wild type (WT) mice and knockout mice that have low or absent expression of different opsonin proteins. In vitro, MWNPs with a PC exhibited increased target cell uptake and decreased macrophage uptake compared to unwrapped NPs with a PC. Proteomics revealed apolipoprotein B as the dominant opsonin on both NP types after incubation in mouse, bovine, or human serum, with other proteins like complement, immunoglobulins, and apolipoproteins also being present. Biodistribution studies indicated a complex interplay between the PC and targeting/clearance, where complement component 3 and immunoglobulin G adsorption on MWNPs led to macrophage clearance but also enabled HSPC targeting. Meanwhile, apolipoprotein E adsorption facilitated hepatocyte clearance but reduced immune cell uptake in the liver. Future research on PCs could determine whether these mechanisms are generalizable to other types of MWNPs, potentially revealing strategies to enhance their effectiveness as delivery systems.

Indexed as

Hematopoietic Stem CellsMacrophagesNanoparticlesProtein CoronaAnimalsCattleCell MembraneHumansMiceMice, Inbred C57BLMice, KnockoutTissue DistributionProtein Coronabiomimicryimmune clearancein vivo targetingnanoparticle biodistributionopsonization

Identifiers

PMID41021803
PMCPMC12519180

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.